JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.63B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.83B |
| 3 |
JPMorgan BetaBuilders International Equity ETF
BBIN
|
+$1.55B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$884M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.8B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.77B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$884M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$880M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$834M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.09% |
| 2 | Technology | 16.19% |
| 3 | Financials | 10.76% |
| 4 | Healthcare | 10.54% |
| 5 | Consumer Discretionary | 10.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
CDTX
4701
DELISTED
Cidara Therapeutics
CDTX
| $41K | ﹤0.01% |
+562
| New | +$36.4K |
2020 Q2
0 quarters
|
|
4702
Comp X International
CIX
$461M
| $41K | ﹤0.01% |
2,936
-1,330
| -31% | -$19K |
2016 Q4
14 quarters
|
|
4703
iShares Emerging Markets Equity Factor ETF
EMGF
$1.96B
| $41K | ﹤0.01% |
1,035
| – | – |
2018 Q4
6 quarters
|
|
4704
iShares S&P GSCI Commodity-Indexed Trust
GSG
$1.03B
| $41K | ﹤0.01% |
+3,891
| New | +$37.1K |
2020 Q2
0 quarters
|
|
4705
iShares US Transportation ETF
IYT
$2.07B
| $41K | ﹤0.01% |
1,012
-796
| -44% | -$30.2K |
2013 Q2
28 quarters
|
|
4706
Lexicon Pharmaceuticals
LXRX
$810M
| $41K | ﹤0.01% |
20,191
+105
| +0.5% | +$206 |
2015 Q3
19 quarters
|
|
4707
Prospect Capital
PSEC
$1.07B
| $41K | ﹤0.01% |
8,000
-184,141
| -96% | -$862K |
2015 Q2
20 quarters
|
|
4708
Pixelworks
PXLW
$42.5M
| $41K | ﹤0.01% |
+1,063
| New | +$46K |
2020 Q2
0 quarters
|
|
4709
Arq
ARQ
$84.7M
| $41K | ﹤0.01% |
8,374
-5,928
| -41% | -$34.2K |
2017 Q2
12 quarters
|
|
|
AIF
4710
DELISTED
Apollo Tactical Income Fund Inc.
AIF
| $41K | ﹤0.01% |
3,300
-497
| -13% | -$5.9K |
2015 Q4
18 quarters
|
|
|
AXLA
4711
DELISTED
Axcella Health Inc. Common Stock
AXLA
| $41K | ﹤0.01% |
300
-1,022
| -77% | -$125K |
2019 Q2
4 quarters
|
|
|
SEAC
4712
DELISTED
Seachange International Inc
SEAC
| $41K | ﹤0.01% |
+1,384
| New | +$64.8K |
2020 Q2
0 quarters
|
|
|
HTZ
4713
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $41K | ﹤0.01% |
29,480
-473,055
| -94% | -$1.5M |
2016 Q3
15 quarters
|
|
4714
iShares Core Moderate Allocation ETF
AOM
$1.87B
| $40K | ﹤0.01% |
1,010
-305
| -23% | -$11.8K |
2016 Q2
16 quarters
|
|
4715
Legacy Housing
LEGH
$698M
| $40K | ﹤0.01% |
2,796
+945
| +51% | +$10.7K |
2019 Q1
5 quarters
|
|
4716
RCI Hospitality Holdings
RICK
$203M
| $40K | ﹤0.01% |
2,918
-16,943
| -85% | -$207K |
2016 Q1
17 quarters
|
|
|
FRGI
4717
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $40K | ﹤0.01% |
6,240
-1,642
| -21% | -$11.4K |
2016 Q4
14 quarters
|
|
|
GCAP
4718
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $40K | ﹤0.01% |
6,695
+496
| +8% | +$3.05K |
2017 Q4
10 quarters
|
|
|
ATXS
4719
DELISTED
Astria Therapeutics
ATXS
| $39K | ﹤0.01% |
1,011
-1,066
| -51% | -$38K |
2019 Q1
5 quarters
|
|
4720
Evolus
EOLS
$472M
| $39K | ﹤0.01% |
7,375
+1,424
| +24% | +$6.56K |
2018 Q1
9 quarters
|
|
4721
Schwab Fundamental US Large Company Index ETF
FNDX
$27.3B
| $39K | ﹤0.01% |
3,150
-360
| -10% | -$4.24K |
2018 Q3
7 quarters
|
|
4722
ProShares Ultra Technology
ROM
$1.44B
| $39K | ﹤0.01% |
1,680
-360
| -18% | -$6.88K |
2018 Q4
6 quarters
|
|
4723
Savara
SVRA
$988M
| $39K | ﹤0.01% |
15,656
+4,530
| +41% | +$11K |
2018 Q1
9 quarters
|
|
|
VOXX
4724
DELISTED
VOXX International Corporation Class A
VOXX
| $39K | ﹤0.01% |
+6,669
| New | +$33.1K |
2020 Q2
0 quarters
|
|
|
RCA
4725
DELISTED
Ready Capital Corporation 7.00% Convertible Senior Notes due 2023
RCA
| $39K | ﹤0.01% |
+1,900
| New | +$33.8K |
2020 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2020 Portfolio in Review
As of Q2 2020, JP Morgan Chase held 5,976 positions worth $518B, up 22% from $426B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q2 2020 filing shows 640 new, 2,055 increased, 2,340 reduced and 398 closed positions. Its largest new stake was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B. The largest sale was iShares Core MSCI EAFE ETF, an estimated $1.8B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 28% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q2 2020 buy was JPMorgan BetaBuilders International Equity ETF: 35,626,738 shares worth $1.64B.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2020, an estimated $2.63B increase.
- JP Morgan Chase's biggest Q2 2020 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $1.8B.
- JP Morgan Chase fully exited Allergan plc in Q2 2020, selling an estimated $656M.
- JP Morgan Chase's ten largest holdings make up 17% of its $518B portfolio in Q2 2020.
- JP Morgan Chase opened 640 new positions and closed 398 in Q2 2020.
- JP Morgan Chase's portfolio value rose 22% quarter-over-quarter to $518B.
Based on JP Morgan Chase's 13F filing for Q2 2020, filed 11 Aug 2020.